Pi Health, a global health technology and clinical research company, today announced a strategic collaboration with GSK to deliver fully outsourced clinical research services. The partnership aims to meaningfully improve the speed and efficiency of the clinical trial process. Under…
Summit Therapeutics Inc. announced that data from the Phase III HARMONi-6 trial will be highlighted during the prestigious Presidential Symposium at the upcoming European Society for Medical Oncology (ESMO) Congress 2025, taking place in Berlin, Germany, from October 17–21, 2025.…
Kinea Bio Inc., a biotechnology company dedicated to developing transformative genetic medicines, announced today two major milestones that significantly advance its lead gene therapy program for dysferlinopathy, a rare and debilitating neuromuscular disease. The company has secured a commitment of…
Virtuoso Surgical, Inc., a Nashville-based medical technology company developing a first-of-its-kind class of robotic tools for rigid endoscopic surgery, announced today that its Virtuoso Surgical Robotic System has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).…
Drug Farm, a private biotechnology company pioneering the use of genetics and artificial intelligence to discover and develop innovative immune-modulating therapies, announced today that it has entered into a Material Transfer Agreement (MTA) with Cincinnati Children’s Hospital Medical Center (CCHMC).…
Merck, a leading science and technology company, and Siemens, a global technology leader, have announced the signing of a new Memorandum of Understanding (MoU) that significantly extends their ongoing strategic partnership. The agreement is designed to accelerate digital transformation in…
Exact Sciences Corp., a leader in cancer screening and diagnostic testing, has announced a new awareness campaign in collaboration with actor and horror film icon Matthew Lillard. The initiative aims to motivate adults aged 45 and older to get screened…
Bayer announced significant progress today in its efforts to develop new treatment options for Parkinson’s disease (PD), a chronic and progressive neurodegenerative disorder that affects millions of people worldwide. The company reported two important clinical trial milestones: the initiation of…
Genentech’s Giredestrant Boosts PFS in ER+ Advanced Breast Cancer Genentech, a member of the Roche Group, announced encouraging results from the Phase III evERA study evaluating its investigational oral selective estrogen receptor degrader (SERD), giredestrant, in combination with everolimus. The…
Aptar Pharma, a global leader in drug delivery and active material science solutions, announced that its Unidose Liquid System (UDS) has been selected as the delivery technology for Enbumyst™ (Bumetanide Nasal Spray) 0.5 mg, recently approved by the U.S. Food…
VectorY Therapeutics, a biotechnology company pioneering vectorized antibody therapies for neurodegenerative diseases, and Shape Therapeutics Inc. (“ShapeTX”), a leader in applying AI and RNA technologies to engineer next-generation genetic medicines, announced today that they have entered into an option and…
Immuto Scientific today announced the closing of an oversubscribed $8 million Seed 2 financing round alongside a new drug discovery collaboration with Daiichi Sankyo, a leading global pharmaceutical company. The funding and collaboration represent significant milestones for Immuto as it…